Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Cumberland Pharmaceuticals Shares Outstanding 2009-2020 | CPIX

Cumberland Pharmaceuticals shares outstanding from 2009 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Cumberland Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 15
2019 15
2018 16
2017 16
2016 16
2015 17
2014 18
2013 18
2012 20
2011 21
2010 21
2009 18
2008 17
Cumberland Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 15
2020-09-30 15
2020-06-30 15
2020-03-31 16
2019-12-31 15
2019-09-30 15
2019-06-30 16
2019-03-31 16
2018-12-31 16
2018-09-30 16
2018-06-30 16
2018-03-31 16
2017-12-31 16
2017-09-30 16
2017-06-30 16
2017-03-31 16
2016-12-31 16
2016-09-30 17
2016-06-30 16
2016-03-31 16
2015-12-31 17
2015-09-30 17
2015-06-30 17
2015-03-31 17
2014-12-31 18
2014-09-30 18
2014-06-30 18
2014-03-31 18
2013-12-31 18
2013-09-30 18
2013-06-30 18
2013-03-31 19
2012-12-31 20
2012-09-30 20
2012-06-30 20
2012-03-31 20
2011-12-31 21
2011-09-30 21
2011-06-30 21
2011-03-31 21
2010-12-31 21
2010-09-30 21
2010-06-30 21
2010-03-31 21
2009-12-31 18
2009-09-30 19
2009-06-30 16
2009-03-31 16
2008-12-31
2008-09-30 17
2008-06-30 16
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.047B $0.037B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.926B 41.52
Takeda Pharmaceutical (TAK) Japan $54.436B 9.97
Astellas Pharma (ALPMY) Japan $27.778B 17.15
Eisai (ESALY) Japan $19.912B 22.09
Catalent (CTLT) United States $18.599B 49.22
Grifols, S.A (GRFS) Spain $12.376B 14.40
Jazz Pharmaceuticals (JAZZ) Ireland $9.091B 15.18
United Therapeutics (UTHR) United States $9.059B 17.59
Neurocrine Biosciences (NBIX) United States $8.770B 20.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.677B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.451B 0.00
Evotec AG (EVTCY) Germany $6.224B 420.28
Ionis Pharmaceuticals (IONS) United States $5.967B 0.00
Orion OYJ (ORINY) Finland $5.789B 0.00
Sage Therapeutics (SAGE) United States $4.473B 0.00
Turning Point Therapeutics (TPTX) United States $3.867B 0.00
Hypermarcas (HYPMY) Brazil $3.737B 14.75
ChemoCentryx (CCXI) United States $3.446B 0.00
Nektar Therapeutics (NKTR) United States $3.396B 0.00
Tilray (TLRY) Canada $3.394B 0.00
PTC Therapeutics (PTCT) United States $3.347B 0.00
Cronos Group (CRON) Canada $3.199B 0.00
Revolution Medicines (RVMD) United States $3.131B 0.00
Relay Therapeutics (RLAY) United States $3.040B 0.00
Pacira BioSciences (PCRX) United States $2.994B 50.56
Organogenesis Holdings (ORGO) United States $2.923B 175.69
Taro Pharmaceutical Industries (TARO) Israel $2.786B 17.26
Corcept Therapeutics (CORT) United States $2.661B 26.68
Xencor (XNCR) United States $2.345B 0.00
USANA Health Sciences (USNA) United States $2.060B 17.05
BioCryst Pharmaceuticals (BCRX) United States $1.813B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.787B 11.46
FibroGen (FGEN) United States $1.700B 0.00
Sundial Growers (SNDL) Canada $1.660B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.640B 12.90
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.631B 0.00
Heron Therapeutics (HRTX) United States $1.517B 0.00
AlloVir (ALVR) United States $1.511B 0.00
ImmunoGen (IMGN) United States $1.510B 0.00
Aclaris Therapeutics (ACRS) United States $1.500B 0.00
Endo (ENDP) Ireland $1.429B 2.16
Indivior (INVVY) United States $1.396B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.366B 0.00
Translate Bio (TBIO) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.256B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
Trillium Therapeutics (TRIL) Canada $1.073B 0.00
4D Molecular Therapeutics (FDMT) $1.006B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.983B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.914B 0.00
Aerie Pharmaceuticals (AERI) United States $0.883B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Collegium Pharmaceutical (COLL) United States $0.821B 30.70
Bioventus (BVS) United States $0.781B 0.00
Esperion Therapeutics (ESPR) United States $0.753B 0.00
Karyopharm Therapeutics (KPTI) United States $0.752B 0.00
Harpoon Therapeutics (HARP) United States $0.735B 0.00
Ardelyx (ARDX) United States $0.734B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.687B 0.00
Rafael Holdings (RFL) United States $0.685B 0.00
VAXART, INC (VXRT) United States $0.651B 0.00
KalVista Pharmaceuticals (KALV) United States $0.636B 0.00
Chinook Therapeutics (KDNY) United States $0.628B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.568B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.564B 0.00
Sigilon Therapeutics (SGTX) $0.559B 0.00
Nanobiotix S.A (NBTX) $0.558B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.555B 0.00
Siga Technologies (SIGA) United States $0.545B 9.10
TherapeuticsMD (TXMD) United States $0.531B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.513B 0.00
Altimmune (ALT) United States $0.479B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.472B 0.00
Akebia Therapeutics (AKBA) United States $0.470B 0.00
Summit Therapeutics (SMMT) United States $0.467B 0.00
Molecular Templates (MTEM) United States $0.461B 0.00
AVITA Medical (RCEL) United States $0.456B 0.00
Foghorn Therapeutics (FHTX) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.450B 10.56
Jounce Therapeutics (JNCE) United States $0.444B 0.00
DURECT (DRRX) United States $0.420B 0.00
PROFOUND MEDICL (PROF) Canada $0.416B 0.00
Oncternal Therapeutics (ONCT) United States $0.408B 0.00
Flexion Therapeutics (FLXN) United States $0.405B 0.00
MEI Pharma (MEIP) United States $0.387B 0.00
Nature's Sunshine Products (NATR) United States $0.387B 18.44
Acutus Medical (AFIB) United States $0.371B 0.00
Innate Pharma SA (IPHYF) France $0.347B 0.00
Redhill Biopharma (RDHL) Israel $0.339B 0.00
Clever Leaves Holdings (CLVR) United States $0.318B 0.00
VYNE Therapeutics (VYNE) United States $0.308B 0.00
Infinity Pharmaceuticals (INFI) United States $0.293B 0.00
CASI Pharmaceuticals (CASI) United States $0.284B 0.00
Alpine Immune Sciences (ALPN) United States $0.271B 0.00
KemPharm (KMPH) United States $0.260B 0.00
Taiwan Liposome (TLC) Taiwan $0.256B 0.00
Xeris Pharmaceuticals (XERS) United States $0.253B 0.00
Jaguar Animal Health (JAGX) United States $0.241B 0.00
Progenity (PROG) United States $0.233B 0.00
Iterum Therapeutics (ITRM) Ireland $0.233B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.230B 0.00
Novan (NOVN) United States $0.224B 0.00
Inotiv (NOTV) United States $0.222B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.208B 0.00
Lannett Co Inc (LCI) United States $0.205B 6.88
Sierra Oncology (SRRA) Canada $0.204B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.200B 0.00
CTI BioPharma (CTIC) United States $0.198B 0.00
IMV INC (IMV) Canada $0.196B 0.00
Onconova Therapeutics (ONTX) United States $0.194B 0.00
Heat Biologics (HTBX) United States $0.189B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Vivos Therapeutics (VVOS) $0.174B 0.00
SCYNEXIS (SCYX) United States $0.174B 0.00
Calithera Biosciences (CALA) United States $0.172B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.169B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.167B 0.00
Qilian Holding Group (QLI) China $0.165B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
GlycoMimetics (GLYC) United States $0.149B 0.00
Concert Pharmaceuticals (CNCE) United States $0.147B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.143B 0.00
Genocea Biosciences (GNCA) United States $0.142B 0.00
Nutriband (NTRB) United States $0.140B 0.00
Lipocine (LPCN) United States $0.136B 0.00
Aziyo Biologics (AZYO) United States $0.135B 0.00
PolarityTE (PTE) United States $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.119B 0.00
Minerva Neurosciences (NERV) United States $0.114B 44.50
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
Otonomy (OTIC) United States $0.108B 0.00
Assertio Holdings (ASRT) United States $0.106B 0.00
Savara (SVRA) United States $0.106B 0.00
Natural Alternatives (NAII) United States $0.103B 28.05
Recro Pharma (REPH) United States $0.101B 0.00
Regulus Therapeutics (RGLS) United States $0.100B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.098B 0.00
ElectroCore (ECOR) United States $0.095B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.085B 0.00
Baudax Bio (BXRX) United States $0.082B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.077B 0.00
Brickell Biotech (BBI) United States $0.071B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
Sigyn Therapeutics (SIGY) United States $0.067B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.065B 0.00
Biomerica (BMRA) United States $0.063B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.062B 0.00
HANCOCK JAFFE (HJLI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Inhibikase Therapeutics (IKT) United States $0.056B 0.00
CV Sciences (CVSI) United States $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Viracta Therapeutics (VIRX) United States $0.044B 0.00
Mannatech (MTEX) United States $0.042B 7.54
RXi Pharmaceuticals (PHIO) United States $0.037B 0.00
4D Pharma (LBPS) United Kingdom $0.035B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.033B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
JanOne (JAN) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.021B 16.85
Plus Therapeutics (PSTV) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
SHINECO INC (TYHT) China $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00